JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Carpal tunnel syndrome.

PURPOSE OF REVIEW: Carpal tunnel syndrome, though generally successfully treated by surgical decompression, still results in significant morbidity. The causes remain unclear and there is uncertainty about appropriate investigations for diagnosis and assessment of severity. The best nonsurgical treatment is yet to be fully elucidated. Recent work has begun to cast some light on these uncertainties.

RECENT FINDINGS: The pathology of idiopathic carpal tunnel syndrome is a noninflammatory fibrosis of the subsynovial connective tissue surrounding the flexor tendons. Biochemical studies of surgical specimens suggest that a variety of regulatory molecules may be inducing fibrous and vascular proliferation and that this may be a response to mechanical stresses. Ultrasound imaging has begun to demonstrate its ability to accurately image the carpal canal contents and the diagnostic value of measurements of median nerve cross-sectional area showing expansion of the nerve is becoming established. The sensitivity and specificity of such measurements may be comparable to those of nerve conduction studies, though their prognostic value remains unknown. Nonsurgical treatment with steroid injection may be a more effective treatment than previously recognized, and is under used.

SUMMARY: Suspected carpal tunnel syndrome should be investigated first with nerve conduction studies but consideration should be given to the use of magnetic resonance imaging or ultrasound imaging when diagnostic uncertainty remains, or there is a suspicion of a space occupying lesion in the carpal canal, especially if endoscopic surgery is contemplated. Treatment by local steroid injection should be considered a valid alternative treatment, at least for milder cases.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app